Simplex Trading’s ACELYRIN SLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,900
Closed -$17K 9654
2025
Q1
$17K Buy
6,900
+6,300
+1,050% +$15K ﹤0.01% 6720
2024
Q4
$1K Sell
600
-1,600
-73% -$7.75K ﹤0.01% 8317
2024
Q3
$10K Sell
2,200
-200
-8% -$1.03K ﹤0.01% 7203
2024
Q2
$10K Sell
2,400
-15,100
-86% -$70.8K ﹤0.01% 7448
2024
Q1
$118K Sell
17,500
-13,700
-44% -$104K ﹤0.01% 5426
2023
Q4
$232K Buy
31,200
+22,300
+251% +$190K ﹤0.01% 4519
2023
Q3
$90K Buy
8,900
+8,300
+1,383% +$176K ﹤0.01% 5201
2023
Q2
$12K Buy
+600
New +$12.3K ﹤0.01% 7265

Other funds holding SLRN

Simplex Trading's SLRN Position: Q1 2025 in Review

Simplex Trading sold out of ACELYRIN (SLRN) in Q1 2025, closing a stake of 4,899 shares — an estimated $11.6K sold.

Simplex Trading first reported a position in SLRN in Q2 2023 and held it in 4 quarters. The position peaked at $124K in Q1 2024. 105 funds tracked by Wall St. Rank hold SLRN as of Q1 2025.

  • Simplex Trading reported no remaining ACELYRIN position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 4,899 ACELYRIN shares in Q1 2025, an estimated $11.6K.
  • Simplex Trading first reported a position in ACELYRIN in Q2 2023 and held it in 4 quarters.
  • Simplex Trading's ACELYRIN position peaked at $124K in Q1 2024.
  • 105 funds tracked by Wall St. Rank held ACELYRIN as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.